AD hidden hematologic risk: clonal hematopoiesis of indeterminate potential (CHIP) + An unusual facial bump related to AD + Switching off selectively skin lipid synthesis: a reversible human model of ceramide depletion + Beyond the skin: suicidal risk is real in AD + Complement, an overlooked driver of Th2 Immunity in AD
Read MoreHow COVID Quarantine May Have Fueled Infantile AD + Hidden Signs of Pruritus in Infants with AD + From Modeling Temperature Fluctuations to Blocking TRPV1: Restoring the Skin Barrier and Treating Pruritus + Can Early Short-Term Moisturizer Use Rewrite an Infant’s Microbiome and Prevent Atopic Dermatitis? + Serine Sensing System for tracking moisturizer treatment of a patient with AD
Read MoreCrusted Scabies and Dupilumab: A Case from Brazil + Seasonal Severity of AD by Birth Season: What’s the Culprit? + Primary Atopic Disorders (PADs): When Should This Be Considered? + Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) Lower the Risk of New-Onset Atopic Dermatitis in Diabetic Patients: Another Clue in the Salt Debate? + Targeting the OX40-OX40L Pathway: A New Era in AD Management?
Read More